Assess patient for nausea, vomiting, anorexia, thirst, severe constipation, paralytic ileus, and bradycardia
Calcium glubionate (or glubionate calcium) is a mineral supplement to prevent or treat low blood calcium levels in people who do not get enough calcium from their diets.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceftriaxone | The risk or severity of adverse effects can be increased when Calcium glubionate anhydrous is combined with Ceftriaxone. |
| Dobutamine | The therapeutic efficacy of Dobutamine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Calcium acetate | The risk or severity of adverse effects can be increased when Calcium glubionate anhydrous is combined with Calcium acetate. |
| Digoxin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Digoxin. |
| Acetyldigitoxin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. |
| Deslanoside | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Deslanoside. |
| Ouabain | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Ouabain. |
| Digitoxin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Digitoxin. |
| Oleandrin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Oleandrin. |
| Cymarin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Cymarin. |
| Proscillaridin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Proscillaridin. |
| Metildigoxin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Metildigoxin. |
| Lanatoside C | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Lanatoside C. |
| Gitoformate | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Gitoformate. |
| Acetyldigoxin | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Acetyldigoxin. |
| Peruvoside | Calcium glubionate anhydrous may increase the arrhythmogenic and cardiotoxic activities of Peruvoside. |
| Doxycycline | The serum concentration of Doxycycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Lymecycline | The serum concentration of Lymecycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Clomocycline | The serum concentration of Clomocycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Oxytetracycline | The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Demeclocycline | The serum concentration of Demeclocycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Tetracycline | The serum concentration of Tetracycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Metacycline | The serum concentration of Metacycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Minocycline | The serum concentration of Minocycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Sarecycline | The serum concentration of Sarecycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Omadacycline | The serum concentration of Omadacycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Penimepicycline | The serum concentration of Penimepicycline can be decreased when it is combined with Calcium glubionate anhydrous. |
| Methyclothiazide | Methyclothiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Chlorthalidone | Chlorthalidone may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Bendroflumethiazide | Bendroflumethiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Metolazone | Metolazone may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Benzthiazide | Benzthiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Hydroflumethiazide | Hydroflumethiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Indapamide | Indapamide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Chlorothiazide | Chlorothiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Hydrochlorothiazide | Hydrochlorothiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Trichlormethiazide | Trichlormethiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Polythiazide | Polythiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Quinethazone | Quinethazone may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Cyclopenthiazide | Cyclopenthiazide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Epitizide | Epitizide may decrease the excretion rate of Calcium glubionate anhydrous which could result in a higher serum level. |
| Calcitriol | The risk or severity of adverse effects can be increased when Calcitriol is combined with Calcium glubionate anhydrous. |
| Calcifediol | The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium glubionate anhydrous. |
| Ergocalciferol | The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Calcium glubionate anhydrous. |
| Cholecalciferol | The risk or severity of adverse effects can be increased when Cholecalciferol is combined with Calcium glubionate anhydrous. |
| Paricalcitol | The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcium glubionate anhydrous. |
| Dihydrotachysterol | The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcium glubionate anhydrous. |
| Alfacalcidol | The risk or severity of adverse effects can be increased when Alfacalcidol is combined with Calcium glubionate anhydrous. |
| Calcipotriol | The risk or severity of adverse effects can be increased when Calcipotriol is combined with Calcium glubionate anhydrous. |
| Seocalcitol | The risk or severity of adverse effects can be increased when Seocalcitol is combined with Calcium glubionate anhydrous. |
| Inecalcitol | The risk or severity of adverse effects can be increased when Inecalcitol is combined with Calcium glubionate anhydrous. |
| Becocalcidiol | The risk or severity of adverse effects can be increased when Becocalcidiol is combined with Calcium glubionate anhydrous. |
| Eldecalcitol | The risk or severity of adverse effects can be increased when Eldecalcitol is combined with Calcium glubionate anhydrous. |
| 1alpha,24S-Dihydroxyvitamin D2 | The risk or severity of adverse effects can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Calcium glubionate anhydrous. |
| Elocalcitol | The risk or severity of adverse effects can be increased when Elocalcitol is combined with Calcium glubionate anhydrous. |
| Maxacalcitol | The risk or severity of adverse effects can be increased when Maxacalcitol is combined with Calcium glubionate anhydrous. |
| Doxercalciferol | The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcium glubionate anhydrous. |
| Vitamin D | The risk or severity of adverse effects can be increased when Vitamin D is combined with Calcium glubionate anhydrous. |
| 1alpha-Hydroxyvitamin D5 | The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium glubionate anhydrous. |
| Tacalcitol | The risk or severity of adverse effects can be increased when Tacalcitol is combined with Calcium glubionate anhydrous. |
| Previtamin D(3) | The risk or severity of adverse effects can be increased when Previtamin D(3) is combined with Calcium glubionate anhydrous. |
| Isradipine | The therapeutic efficacy of Isradipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Diltiazem | The therapeutic efficacy of Diltiazem can be decreased when used in combination with Calcium glubionate anhydrous. |
| Trimethadione | The therapeutic efficacy of Trimethadione can be decreased when used in combination with Calcium glubionate anhydrous. |
| Amlodipine | The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nimodipine | The therapeutic efficacy of Nimodipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nisoldipine | The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Lercanidipine | The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Cinnarizine | The therapeutic efficacy of Cinnarizine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Ethosuximide | The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nicardipine | The therapeutic efficacy of Nicardipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Magnesium sulfate | The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium glubionate anhydrous. |
| Verapamil | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium glubionate anhydrous. |
| Zonisamide | The therapeutic efficacy of Zonisamide can be decreased when used in combination with Calcium glubionate anhydrous. |
| Felodipine | The therapeutic efficacy of Felodipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nitrendipine | The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Perhexiline | The therapeutic efficacy of Perhexiline can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nifedipine | The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Amiodarone | The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium glubionate anhydrous. |
| Carvedilol | The therapeutic efficacy of Carvedilol can be decreased when used in combination with Calcium glubionate anhydrous. |
| Bepridil | The therapeutic efficacy of Bepridil can be decreased when used in combination with Calcium glubionate anhydrous. |
| Mibefradil | The therapeutic efficacy of Mibefradil can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nimesulide | The therapeutic efficacy of Nimesulide can be decreased when used in combination with Calcium glubionate anhydrous. |
| Prenylamine | The therapeutic efficacy of Prenylamine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Cyclandelate | The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium glubionate anhydrous. |
| Flunarizine | The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Fluspirilene | The therapeutic efficacy of Fluspirilene can be decreased when used in combination with Calcium glubionate anhydrous. |
| Clevidipine | The therapeutic efficacy of Clevidipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Methsuximide | The therapeutic efficacy of Methsuximide can be decreased when used in combination with Calcium glubionate anhydrous. |
| Seletracetam | The therapeutic efficacy of Seletracetam can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nylidrin | The therapeutic efficacy of Nylidrin can be decreased when used in combination with Calcium glubionate anhydrous. |
| Ziconotide | The therapeutic efficacy of Ziconotide can be decreased when used in combination with Calcium glubionate anhydrous. |
| Dotarizine | The therapeutic efficacy of Dotarizine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Xylometazoline | The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Calcium glubionate anhydrous. |
| Nilvadipine | The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Tranilast | The therapeutic efficacy of Tranilast can be decreased when used in combination with Calcium glubionate anhydrous. |
| Fasudil | The therapeutic efficacy of Fasudil can be decreased when used in combination with Calcium glubionate anhydrous. |
| Agmatine | The therapeutic efficacy of Agmatine can be decreased when used in combination with Calcium glubionate anhydrous. |
| Fendiline | The therapeutic efficacy of Fendiline can be decreased when used in combination with Calcium glubionate anhydrous. |
| Eperisone | The therapeutic efficacy of Eperisone can be decreased when used in combination with Calcium glubionate anhydrous. |